If you have recently had a cardiac CT scan, you may have seen the words low-density plaque or soft plaque in your results. Your doctor may have described it as high-risk, even if the blockage percentage seemed moderate. That can be confusing: is not a 50 percent blockage less serious than a 90 percent one?
Not necessarily. The percentage of blockage matters less than the stability of the plaque itself, and soft plaque is the least stable kind.
What Is Soft Plaque?
Soft plaque is a buildup inside the walls of your coronary arteries that is still largely composed of fat and inflammatory cells, rather than hardened calcium. Plaque that has hardened and calcified over time is called stable or calcified plaque; soft plaque, sometimes called unstable plaque, is the opposite, active, fatty, and more fragile.
Soft plaque looks different on imaging, behaves differently in the body, and carries a different kind of risk.
What Causes Soft Plaque in Arteries? The Role of LDL Cholesterol Plaque Formation
Understanding soft plaque starts with understanding what LDL cholesterol does inside an artery wall, not just in the bloodstream.
Step 1: LDL enters the artery wall
LDL cholesterol circulates through your blood. When levels are elevated, or when the inner lining of an artery (the endothelium) is inflamed or damaged, LDL particles begin to penetrate the artery wall. Small, dense LDL particles are particularly effective at getting through, which is why doctors increasingly look at LDL particle size, not just total LDL numbers.
Step 2: Oxidation triggers an immune response
Once inside the artery wall, LDL becomes oxidized: it reacts with free radicals in the surrounding tissue and changes chemically. The body recognizes oxidized LDL as a foreign threat and launches an immune response, sending white blood cells called macrophages to the site.
Step 3: Foam cells build the plaque core
Macrophages engulf the oxidized LDL particles but cannot actually clear them. Instead, they become engorged with fat and transform into what scientists call foam cells. Foam cells accumulate inside the artery wall and form the fatty, lipid-rich core that defines soft plaque. The more LDL enters, the more foam cells form, and the larger the core grows. This entire sequence is what doctors mean by LDL cholesterol plaque formation, a process driven by cholesterol, not by cholesterol alone sitting passively in the bloodstream.
Step 4: A thin cap forms over the core
As the plaque grows, the body attempts to contain it by forming a fibrous cap: a layer of smooth muscle cells and collagen that walls off the fatty deposit. In stable, calcified plaque, this cap is thick and durable. In soft plaque, the cap is thin and fragile. The lipid core beneath it remains active, inflamed, and large. This combination, a thin cap over a large fatty core, is what makes soft plaque vulnerable to rupture.
Can Soft Plaque Cause a Heart Attack? Why It Is Considered High-Risk
When a soft plaque cap ruptures, the lipid core spills into the bloodstream. The body responds as it would to any injury: it sends platelets and clotting factors to the site. A clot forms rapidly. If that clot is large enough to block the artery, the result is a heart attack.
This is why a 50 percent soft plaque blockage can cause a heart attack while a 70 percent calcified blockage sometimes does not. The percentage of blockage matters less than the stability of the plaque itself.
Several things increase the risk of rupture: a sudden spike in blood pressure from intense physical exertion, acute emotional stress or anger, exposure to very cold temperatures, and smoking, which directly damages the arterial wall.
Can Soft Plaque in Arteries Be Reversed? Treatment for Soft Plaque
Yes, and this is where the picture becomes more encouraging. Reversing soft plaque generally happens in two stages: first stabilizing it so it is less likely to rupture, then, with sustained treatment, actually reducing its volume over time.
Stabilization
The most immediate goal is stabilizing the plaque so the fibrous cap becomes less likely to rupture. Statins are particularly effective here. Beyond lowering LDL production in the liver, statins reduce inflammation around the plaque and directly strengthen the fibrous cap. This effect can begin within weeks of starting treatment.
Regression
Actual reduction of plaque volume is possible with sustained, aggressive LDL lowering. Clinical trials including ASTEROID and SATURN demonstrated measurable plaque regression in patients who achieved very low LDL levels, typically below 70 mg/dL and in some cases below 50 mg/dL, over 12 to 24 months. High-intensity statins, and in some cases additional medications like ezetimibe or PCSK9 inhibitors, are used to reach these targets.
Diet and lifestyle
Medication works best alongside meaningful dietary change. The Mediterranean diet has direct clinical evidence for plaque stabilization, and the mechanisms are specific. Reducing saturated fat lowers the amount of LDL entering the artery wall. Omega-3 fatty acids from fatty fish, walnuts, and flaxseed reduce the inflammatory signaling that drives foam cell accumulation. Antioxidants from berries, olive oil, and vegetables slow the oxidation of LDL inside the artery wall, which is the step that triggers the entire immune cascade.
Exercise, once cleared by a physician, improves arterial health and reduces systemic inflammation over time.
What “Low-Density Plaque” Means on a CT Report
If your cardiac CT results describe plaque as “primarily low density,” the radiologist is noting that the plaque is still largely composed of lipid-rich material rather than calcified scar tissue. This indicates it is relatively active rather than old and hardened, which is both the reason it is flagged as high-risk and the reason it tends to respond well to intervention.
The biology that makes soft plaque dangerous is the same biology that makes it treatable.
How POD Health Can Support Your Soft Plaque Treatment Through Chronic Care Management
If you have received CT results showing soft or low-density plaque, or if you have questions about your cholesterol levels and cardiovascular risk, POD Health’s Chronic Care Management program can help.
POD Health serves Medicare members across all five boroughs of New York City, including Staten Island, Brooklyn, Queens, the Bronx, and Manhattan, as well as Westchester County and Florida. Our dedicated care coordinators work with Medicare patients to build personalized care plans that address heart health, medication management, and lifestyle, all without leaving home.
If you would like to find out whether you qualify for Chronic Care Management through Medicare, often at little to no out-of-pocket cost depending on your coverage, contact us to speak with a care coordinator.
